Physician

John King, M.D.

According to 2025 Medicare claims, John King, M.D. (NPI: 1255350021) practices ophthalmology in the Little Rock-North Little Rock-Conway, AR market, with the plurality of this provider's patient population coming from Pulaski, AR. This provider's primary affiliated billing organization is RETINA ASSOCIATES, P.A. (NPI: 1447215603; TIN: 71-0706742) and primary practice location at 72205-6243.

King's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,136 traditional Medicare patients, billed 46,787 HCPCS/CPT codes, and received $2,405,754 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 632 prescription claims across 246 beneficiaries totaling $24,461 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 21 records totaling $600. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,202,869 to $2,405,754. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $29,498 and ending at $24,461. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,160	8,992	$1,202,869
2016	1,597	17,486	$1,857,954
2017	1,473	14,262	$1,943,732
2018	1,499	16,897	$2,391,718
2019	1,892	18,279	$3,165,602
2020	1,667	15,256	$2,907,153
2021	1,399	14,946	$2,975,413
2022	1,268	21,098	$2,948,943
2023	1,238	49,138	$2,823,444
2024	1,136	46,787	$2,405,754

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	107	337	$29,498
2016	139	297	$22,413
2017	155	349	$22,973
2018	184	410	$25,452
2019	233	644	$33,048
2020	198	569	$23,920
2021	183	566	$24,086
2022	231	644	$32,653
2023	250	642	$37,878
2024	246	632	$24,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	554	1,547	$80
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	521	548	$77
92012	Established patient problem focused exam of visual system	334	420	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	555	945	$55
92134	Imaging of retina	1,051	2,433	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	203	9,041	$12,303
Combigan	Brimonidine Tartrate/Timolol	11	468	$2,184
Atropine Sulfate	Atropine Sulfate	44	1,446	$1,578
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	48	910	$578
Ketorolac Tromethamine	Ketorolac Tromethamine	19	694	$578

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$600	Alimera Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John King, M.D.?

Tedicare shows public-source Medicare data for John King, M.D. (NPI 1255350021), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John King, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John King, M.D.?

John King, M.D. is linked to RETINA ASSOCIATES, P.A. (billing NPI 1447215603) in the available physician profile data.

Does John King, M.D. have Open Payments data?

John King, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.